Marlins Outfielder Jakob Marsee and Pitcher Tyler Zuber Set for Elbow Surgeries

The Miami Marlins have announced that outfielder Jakob Marsee and right-handed pitcher Tyler Zuber are slated to undergo elbow surgery on Monday following end-of-season medical visits, according to reporting relayed by Kevin Barral of Fish On First and summarized by MLB Trade Rumors. The move indicates that the Marlins believe there is a correctable underlying problem that will require an offseason recovery window for both positions they will need to fill next spring.

Marsee, a Marlins outfielder, and Zuber, a right-hander in the team’s pitching group, reportedly visited Dr. Keith Meister at the end of the season. Appointments with specialized elbow surgeons typically indicate that the team and players have concluded that rest alone will not be enough to get them back to full strength, and that surgical intervention is the most direct path forward.

The Marlins’ decision to pursue surgery for two different arms and at least one impact bat suggests the organization is treating elbow health as a priority across roles. In practical terms, an elbow procedure can influence the timeline for throwing intensity for pitchers and the timeline for full-speed work for position players, especially when the procedure involves the throwing arm, even for everyday tasks.

For Zuber, the surgery meaning is straightforward: Miami will likely have to plan for his absence while he completes a post-operative rehab program. In a season-long roster build, elbow issues can create a chain reaction, forcing the organization to decide who provides innings early in the year and how quickly pitchers can be stretched back to normal workloads. Even without additional details on the specific procedure type, surgery itself is the clearest indicator that he is not expected to be ready immediately for spring workloads.

For Marsee, the stakes are different but still real. An outfielder’s elbow is frequently tied to throwing mechanics, ranging throws, and long-distance fundamentals that do not simply come back with time off. While offseason surgery is not automatically tied to a definitive return date, the Marlins now have to account for the possibility that his role could be limited into the next season, making depth in the outfield and alternative offensive options more important for the early weeks of the 2027 season.

What to watch next is how the Marlins communicate recovery timelines and whether they provide any operational details about the rehab plan. If the team issues formal updates, fans will look for whether both surgeries were similar in scope or were handled differently, as that can change expectations for pitchers and position players. In the meantime, Miami’s offseason roster construction will likely feature an emphasis on health, particularly in the areas where Zuber and Marsee would ordinarily contribute.

Because this report is based on third-party attribution of the team’s plan and does not spell out medical specifics, readers should treat the broader implications as conditional. Still, two scheduled elbow surgeries at the same offseason checkpoint is a meaningful organizational development, and it will shape how the Marlins distribute playing time and pitching opportunities once spring arrives.